跳至主要内容
临床试验/NCT07581860
NCT07581860尚未招募不适用

Growth Hormone Resistance of Beta-cells in People With Impaired Fasting Glucose vs Impaired Glucose Tolerance

University of Missouri-Columbia1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
10
试验地点
1

研究概览

简要总结

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • body mass index >18.5kg/m2 and <45.9kg/m2
  • impaired fasting glucose >/= 100mg/dL, </= 126mg/dL or impaired glucose tolerance on 75g oral glucose tolerance test (blood glucose 140 to 199mg/dL at two-hours)

排除标准

  • pregnant, planning to become pregnant during the study, or breastfeeding
  • current diagnosis or history of type 1 or type 2 diabetes
  • use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
  • history of bariatric surgery
  • known, uncontrolled hypothyroidism
  • history of intracranial hypertension, including papilledema, or a condition that increases the risk of developing intracranial hypertension, such as Turner Syndrome, Prader-Willi Syndrome, or renal impairment
  • current cancer or cancer that has been in remission less than 5 years
  • first degree relative with type 1 diabetes
  • evidence of anemia or significant end organ dysfunction (e.g., liver, kidney, heart disease)
  • alcohol use disorder, use of controlled substances, or smoking >2 cigarettes per day
  • greater than 3% weight loss within three months of screening or engaged in regular (>/= 3 days per week), continuous moderate- or high-intensity exercise of >/= 30 min duration
  • mentally disabled persons, prisoners, and persons with inability to grant voluntary informed consent

研究组 & 干预措施

Impaired fasting glucose

Impaired glucose tolerance

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bettina Mittendorfer

Senior Associate Dean for Research; Professor, Medicine & Nutrition; NextGen Director of Clinical and Translational Sciences Unit

University of Missouri-Columbia

研究点 (1)

Loading locations...

相似试验